In responders post-treatment, PD-1+ CD4+ T cells increase GZMB expression and move closer to tumor cells, similar to the granzyme-perforin-dependent tumor-killing mechanism used by cytotoxic CD8+ T cells48–51. Here, PRF1 is linked to neoplasm.